Literature DB >> 24144585

Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.

Jia Liu1, Yu-Tao Xiang, Hui Lei, Qian Wang, Gang Wang, Gabor S Ungvari, David W Morris, Xiong-Zhao Zhu, Kelly Y C Lai, Bao-Liang Zhong, Samuel Y S Wong, Ling Zhang, Qinge Zhang, Yu-Chuan Zou, Le Xiao, Qian Zhao, Yang Li, Jiang Wu, Guo-Fu Zhang, Helen F K Chiu.   

Abstract

BACKGROUND: The 16-item Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) is a newly introduced screening tool, while the Montgomery-Asberg Scale (MADRS) is commonly used in research and clinical practice in China. Converting the total scores between the two instruments could facilitate the comparison of different studies.
METHODS: This study included 1164 patients with major depressive disorder (MDD). The diagnosis was established using the Mini International Neuropsychiatric Interview (MINI). The severity of depressive symptoms was assessed with the Chinese versions of MADRS (C-MADRS) and QIDS-SR (C-QIDS-SR) at baseline and 6 weeks later (exit point). Total scores of both scales were converted using Item Response Theory (IRT) analysis.
RESULTS: At baseline, the C-MADRS and C-QIDS-SR were not unifactorial, therefore the conversion between them could not be performed. At exit, the C-MADRS and C-QIDS-SR were unifactorial, meeting the unidimensionality assumption of the IRT approach. Depression severity thresholds for the QIDS-SR are suggested as 6-10 for mild, 11-15 for moderate, 16-20 for severe, 21+ for very severe depression and ≤ 5 for remission (www.ids-qids.org). Based on the results of this study, the corresponding C-MADRS thresholds are 9-17 for mild, 18-24 for moderate, 25-33 for severe, 34+ for very severe depression and ≤ 7 or 8 (7.5) for remission.
CONCLUSIONS: The conversion of C-QIDS-SR and C-MADRS total scores would help researchers understand findings across different studies using these scales.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  China; Conversion; Major depressive disorder; Scale; Self-report

Mesh:

Year:  2013        PMID: 24144585     DOI: 10.1016/j.jad.2013.09.023

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Comorbid Moderate-Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care.

Authors:  Cai-Lan Hou; Xin-Rong Ma; Mei-Ying Cai; Yan Li; Yu Zang; Fu-Jun Jia; Yong-Qiang Lin; Helen F K Chiu; Gabor S Ungvari; Brian J Hall; Bao-Liang Zhong; Xiao-Lan Cao; Yu-Tao Xiang
Journal:  Community Ment Health J       Date:  2016-06-15

2.  Evaluation of the Paper and Smartphone Versions of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) and the Patient Health Questionnaire-9 (PHQ-9) in Depressed Patients in China.

Authors:  Long Zhen; Gang Wang; Gailing Xu; Le Xiao; Lei Feng; Xu Chen; Man Liu; Xuequan Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-17       Impact factor: 2.570

3.  Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: An Advanced Exploration.

Authors:  Qiaoqiao Lu; Jianbo Lai; Haifeng Lu; Chee Ng; Tingting Huang; Hua Zhang; Kaijing Ding; Zheng Wang; Jiajun Jiang; Jianbo Hu; Jing Lu; Shaojia Lu; Tingting Mou; Dandan Wang; Yanli Du; Caixi Xi; Hailong Lyu; Jingkai Chen; Yi Xu; Zhuhua Liu; Shaohua Hu
Journal:  Front Psychiatry       Date:  2019-10-29       Impact factor: 4.157

4.  SIGMA-VB: Validity and reliability of the Brazilian Portuguese version of the Montgomery-Åsberg Depression Rating Scale using the Structured Interview Guide for the MADRS.

Authors:  Fernando Fernandes; Adriana Carneiro; Rodolfo N Campos; Marcio G Soeiro-de-Souza; Vivian B Barros; Ricardo A Moreno
Journal:  Braz J Psychiatry       Date:  2019-02-18       Impact factor: 2.697

5.  Prevalence and clinical correlates of insomnia symptoms and their association with quality of life in Chinese patients with HBV-related liver disease.

Authors:  Jing Zhao; Mei Liu; Gabor S Ungvari; Chee H Ng; Ines Hang Iao Chow; Ting Wang; Yu Chen; Zhongping Duan; Yu-Tao Xiang; Su-Jun Zheng
Journal:  PeerJ       Date:  2021-03-04       Impact factor: 2.984

6.  Protocol for a prospective open-label clinical trial to investigate the utility of concurrent TBS/fNIRS for antidepressant treatment optimisation.

Authors:  Rebecca L D Kan; Arthur D P Mak; Sherry K W Chan; Bella B B Zhang; Kenneth N K Fong; Georg S Kranz
Journal:  BMJ Open       Date:  2022-02-10       Impact factor: 2.692

7.  Validation of the Malay Self-Report Quick Inventory of Depressive Symptomatology in a Malaysian Sample.

Authors:  Lai Fong Chan; Choon Leng Eu; Seng Fah Tong; Song Jie Chin; Shalisah Sharip; Yee Chin Chai; Jiann Lin Loo; Nurul Ain Mohamad Kamal; Jo Aan Goon; Raynuha Mahadevan; Chian Yong Liu; Chih Nie Yeoh; Tuti Iryani Mohd Daud
Journal:  Int J Environ Res Public Health       Date:  2022-02-28       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.